PedAM

Pediatric Disease Annotations & Medicines

Disease	prostate cancer
Symptom	C0011570\|depression
Sentences	11
PubMedID- 26002689	A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance.
PubMedID- 24625637	Objectives: to systematically review the literature pertaining to the prevalence of depression and anxiety in patients with prostate cancer as a function of treatment stage.
PubMedID- 24700681	Conclusion: adequate and reliable assessment of depression in men diagnosed with prostate cancer may require use of additional symptoms to those listed for mdd, and treatment planning and delivery could be more precise and effective using this methodology.
PubMedID- 21837637	The burden of depression in prostate cancer.
PubMedID- 25443144	Objective: we sought to analyze the prevalence and incremental burden of depression among elderly with prostate cancer.
PubMedID- 23398917	The effects of psychosocial strategies on anxiety and depression of patients diagnosed with prostate cancer: a systematic review.
PubMedID- 21882934	Stage of disease progression moderates the association between social support and depression in prostate cancer survivors.
PubMedID- 22459065	Purpose: current literature describes concern for an increase in depression owing to treatment of prostate cancer.
PubMedID- 22855322	Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
PubMedID- 23454601	Analyses of the discussion forum section revealed that higher levels of social support and lower level of symptom distress and depression among men with prostate cancer were associated with low use of the forum (table 9).
PubMedID- 25745628	The increased incidence and prevalence of depression in men with prostate cancer is cause for concern for an increased risk of suicidal ideation and behavior in such patients.

Page: 1